| 摘要 |
The present invention pertains to a therapeutic composition for disseminated intravascular coagulation syndrome, disseminated intravascular coagulation syndrome associated with a decrease in antithrombin, or thrombophilia based on hereditary antithrombin deficiency, the therapeutic composition containing antithrombin gamma. |
